A detailed history of Enterprise Bank & Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Enterprise Bank & Trust CO holds 28,256 shares of ABT stock, worth $3.23 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
28,256
Previous 28,425 0.59%
Holding current value
$3.23 Million
Previous $2.95 Million 9.08%
% of portfolio
1.04%
Previous 1.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$100.07 - $118.13 $16,911 - $19,963
-169 Reduced 0.59%
28,256 $3.22 Million
Q2 2024

Jul 10, 2024

BUY
$100.73 - $112.44 $8,159 - $9,107
81 Added 0.29%
28,425 $2.95 Million
Q1 2024

Apr 10, 2024

SELL
$109.52 - $120.96 $75,459 - $83,341
-689 Reduced 2.37%
28,344 $3.22 Million
Q4 2023

Jan 09, 2024

BUY
$90.19 - $110.4 $202,115 - $247,406
2,241 Added 8.36%
29,033 $3.2 Million
Q3 2023

Oct 16, 2023

SELL
$95.53 - $114.62 $1,146 - $1,375
-12 Reduced 0.04%
26,792 $2.59 Million
Q2 2023

Jul 06, 2023

BUY
$100.78 - $112.29 $64,297 - $71,641
638 Added 2.44%
26,804 $2.92 Million
Q1 2023

Apr 11, 2023

BUY
$96.86 - $114.01 $17,725 - $20,863
183 Added 0.7%
26,166 $2.65 Million
Q4 2022

Jan 11, 2023

BUY
$95.06 - $111.52 $148,293 - $173,971
1,560 Added 6.39%
25,983 $0
Q3 2022

Oct 06, 2022

BUY
$96.76 - $112.03 $9,869 - $11,427
102 Added 0.42%
24,423 $2.36 Million
Q2 2022

Jul 06, 2022

SELL
$102.07 - $123.37 $201,894 - $244,025
-1,978 Reduced 7.52%
24,321 $2.64 Million
Q1 2022

Apr 13, 2022

SELL
$114.02 - $139.04 $195,886 - $238,870
-1,718 Reduced 6.13%
26,299 $3.11 Million
Q4 2021

Jan 03, 2022

BUY
$115.53 - $141.46 $24,607 - $30,130
213 Added 0.77%
28,017 $3.94 Million
Q3 2021

Oct 04, 2021

SELL
$116.66 - $129.06 $37,097 - $41,041
-318 Reduced 1.13%
27,804 $3.29 Million
Q2 2021

Jul 06, 2021

BUY
$105.79 - $124.53 $22,956 - $27,023
217 Added 0.78%
28,122 $3.26 Million
Q1 2021

Apr 15, 2021

BUY
$108.84 - $128.23 $20,788 - $24,491
191 Added 0.69%
27,905 $3.34 Million
Q4 2020

Jan 05, 2021

BUY
$105.0 - $114.42 $5,145 - $5,606
49 Added 0.18%
27,714 $3.03 Million
Q3 2020

Oct 16, 2020

SELL
$91.64 - $111.29 $181,813 - $220,799
-1,984 Reduced 6.69%
27,665 $3.01 Million
Q2 2020

Jul 10, 2020

BUY
$76.57 - $98.0 $56,125 - $71,834
733 Added 2.53%
29,649 $2.71 Million
Q1 2020

Apr 07, 2020

SELL
$62.82 - $91.86 $103,464 - $151,293
-1,647 Reduced 5.39%
28,916 $2.28 Million
Q4 2019

Jan 07, 2020

BUY
$78.51 - $87.4 $41,217 - $45,885
525 Added 1.75%
30,563 $2.66 Million
Q3 2019

Oct 07, 2019

BUY
$81.84 - $88.74 $81,758 - $88,651
999 Added 3.44%
30,038 $2.51 Million
Q2 2019

Jul 12, 2019

SELL
$72.88 - $85.0 $2,550 - $2,975
-35 Reduced 0.12%
29,039 $2.44 Million
Q1 2019

Apr 24, 2019

BUY
$66.22 - $80.06 $1.93 Million - $2.33 Million
29,074 New
29,074 $2.32 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Enterprise Bank & Trust CO Portfolio

Follow Enterprise Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Bank & Trust CO with notifications on news.